Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -118,181 | -75,777 | -33,947 | -15,888 | -10,311 |
| Depreciation Amortization | 2,412 | 325 | 144 | 122 | 83 |
| Accounts payable and accrued liabilities | -2,426 | 4,496 | 664 | -66 | 1,131 |
| Other Working Capital | 4,683 | 9,715 | -360 | -396 | 1,655 |
| Other Operating Activity | 19,483 | 9,794 | 3,209 | 719 | -1,107 |
| Operating Cash Flow | $-94,029 | $-51,447 | $-30,290 | $-15,509 | $-8,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,416 | -2,834 | -57 | -121 | -376 |
| Purchase Of Investment | -305,192 | -63,797 | N/A | N/A | N/A |
| Sale Of Investment | 215,867 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -82 | -400 | 0 | 0 | 0 |
| Investing Cash Flow | $-90,823 | $-67,031 | $-57 | $-121 | $-376 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,700 | 113,121 | 113,496 | 9 | 12 |
| Other Financing Activity | 0 | 0 | 72,434 | 9,500 | 11,980 |
| Financing Cash Flow | $92,700 | $113,121 | $185,930 | $9,509 | $11,992 |
| Exchange Rate Effect | -99 | -8 | N/A | N/A | N/A |
| Beginning Cash Position | 150,609 | 155,974 | 391 | 6,512 | 3,445 |
| End Cash Position | 58,358 | 150,609 | 155,974 | 391 | 6,512 |
| Net Cash Flow | $-92,251 | $-5,365 | $155,583 | $-6,121 | $3,067 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,029 | -51,447 | -30,290 | -15,509 | -8,549 |
| Capital Expenditure | -1,416 | -2,834 | -57 | -121 | -376 |
| Free Cash Flow | -95,445 | -54,281 | -30,347 | -15,630 | -8,925 |